GARCHING, Germany & HOUSTON--(BUSINESS WIRE)--ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and RadioMedix Inc., a clinical stage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback